KINGKEY FIN INT (01468) is considering establishing investment opportunities and services related to cryptocurrency licenses under regulatory supervision.
Kingkey Financial International (01468) has announced that the company is considering setting up investments involving cryptocurrency under the supervision of licensing.
KINGKEY FIN INT (01468) has announced that the company is currently considering establishing investment opportunities and services related to cryptocurrency licensing under regulation. The group is currently working with Amber Group to develop investment plans for the group's Bitcoin and other major cryptocurrency investment products. These investment plans will be reviewed and approved by the investment committee based on market conditions and the group's overall financial situation, and then executed by the board of directors. It is expected that the investment plans will be funded from the group's existing cash reserves.
Related Articles
ZHONGSHENJIANYE (02503): The subscription price has been changed to HKD 0.61 per share. Trading will resume at 1:00 pm on July 3rd.
SIMCERE PHARMA(02096): Enze Shu has been approved by the National Medical Products Administration to be launched in China.
SIRNAOMICS-B (02257): Ouyang Yunlong appointed as non-executive director.
ZHONGSHENJIANYE (02503): The subscription price has been changed to HKD 0.61 per share. Trading will resume at 1:00 pm on July 3rd.
SIMCERE PHARMA(02096): Enze Shu has been approved by the National Medical Products Administration to be launched in China.
SIRNAOMICS-B (02257): Ouyang Yunlong appointed as non-executive director.
RECOMMEND
U.S. Senate Passes “Big and Beautiful” Bill, Triggering Surge in Gold Amid Soaring Deficit Concerns
02/07/2025
Declining Demand Triggers Price Drop; Photovoltaic Glass Industry May Be Preparing for a New Round of Coordinated Production Cuts
02/07/2025
Surge in Prices of Chinese-Made Goods Highlights Tariff Impact on U.S. Consumers
02/07/2025
